Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

March 2026

Cirdan Announces £12.9m Investment to Drive Innovation, Skills and Global Growth

2026-05-28T14:59:07+00:00

We were pleased to welcome First Minister Michelle O’Neill, Deputy First Minister Emma Little-Pengelly and Economy Minister Caoimhe Archibald to our headquarters in Lisburn to mark a significant milestone for Cirdan – a £12.9 million investment in innovation, skills development and international expansion. The investment is supported by £1.9 million from Invest Northern Ireland. Advancing Our [...]

Cirdan Announces £12.9m Investment to Drive Innovation, Skills and Global Growth2026-05-28T14:59:07+00:00

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care

2026-03-11T13:51:37+00:00

By Jenna Karpel Breast Cancer: Tumor Biology as the Foundation of Precision Care Breast cancer remains a leading cause of cancer-related mortality worldwide, and prior to the advent of precision medicine, treatment options were limited and outcomes were poor. The discovery of predictive, prognostic, and immunologic biomarkers fundamentally transformed breast cancer diagnosis [...]

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care2026-03-11T13:51:37+00:00

Sectra Highlights the Growing Role of Genomics in Diagnostics at HIMSS 2026

2026-03-10T15:47:13+00:00

Genomics is right now transforming how we diagnose and treat diseases. When clinicians can understand a patient’s unique genetic makeup, they can deliver care that’s earlier, more precise, and better tailored to the individual. “𝙂𝙚𝙣𝙤𝙢𝙞𝙘𝙨 𝙞𝙣 𝙙𝙞𝙖𝙜𝙣𝙤𝙨𝙩𝙞𝙘𝙨 𝙞𝙨 𝙨𝙤𝙧𝙩 𝙤𝙛 𝙖 𝙩𝙧𝙖𝙞𝙣 𝙩𝙝𝙖𝙩 𝙨𝙩𝙖𝙧𝙩𝙨 𝙩𝙤 𝙥𝙞𝙘𝙠 𝙪𝙥 𝙨𝙥𝙚𝙚𝙙. 𝙀𝙞𝙩𝙝𝙚𝙧 𝙮𝙤𝙪'𝙧𝙚 𝙜𝙤𝙞𝙣𝙜 𝙩𝙤 𝙗𝙚 𝙤𝙣 𝙞𝙩 𝙤𝙧 𝙡𝙚𝙛𝙩 𝙖𝙩 [...]

Sectra Highlights the Growing Role of Genomics in Diagnostics at HIMSS 20262026-03-10T15:47:13+00:00

Leica Biosystems Launches a 4-Plex Fluorescent Detection Kit to Advance Cancer Research

2026-03-10T10:56:37+00:00

Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, streamlines multiplex immunofluorescence (IF) for  oncology and translational research with the launch of its BOND 4-Plex Fluorescent Detection Kit for research use only (RUO). The new pre-assembled kit empowers researchers to achieve consistent, high-quality results while preserving tissue morphology.Multiplex-IF enables spatial characterization of the [...]

Leica Biosystems Launches a 4-Plex Fluorescent Detection Kit to Advance Cancer Research2026-03-10T10:56:37+00:00

Europe At A Biotech Crossroads As Digital Gaps Challenge Global Ambitions

2026-03-10T14:19:59+00:00

Autolomous CEO Alexander Seyf outlines why Europe must close its processing deficit, connect intelligence across ecosystems, and prioritise mission driven collaboration to compete with the US and Asia in 2026 In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, offers a candid assessment of Europe’s biotech landscape as it moves into [...]

Europe At A Biotech Crossroads As Digital Gaps Challenge Global Ambitions2026-03-10T14:19:59+00:00

Artificial Intelligence–Enabled Multi-Omics for Predicting Immune Checkpoint Inhibitor Response and Resistance

2026-03-10T14:19:56+00:00

The following abstract is drawn from a recently published paper in Journal of Multidisciplinary Healthcare. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Xiaodong Wang*, Jing He*, Gouping Ding*, [...]

Artificial Intelligence–Enabled Multi-Omics for Predicting Immune Checkpoint Inhibitor Response and Resistance2026-03-10T14:19:56+00:00

Radiology Partners’ approach to clinical AI applications: w/ Nina Kottler, MD, MS, FSIIM | Radiology Partners

2026-03-05T13:29:45+00:00

In this episode, I have the pleasure of speaking with Dr. Nina Kottler, Associate Chief Medical Officer of Clinical AI at Radiology Partners. Nina and I dive deep into the world of AI in radiology and its expanding potential in digital pathology. Together, we explore the entire journey of AI in healthcare—from early rule-based systems [...]

Radiology Partners’ approach to clinical AI applications: w/ Nina Kottler, MD, MS, FSIIM | Radiology Partners2026-03-05T13:29:45+00:00

Techcyte Achieves CE Marking Under IVDR for Fusion AP Digital Pathology Platform

2026-03-09T09:47:05+00:00

Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its Fusion AP platform has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. The device is now registered with the  German Competent Authority and authorized for commercialization across the European Economic Area. The IVDR represents [...]

Techcyte Achieves CE Marking Under IVDR for Fusion AP Digital Pathology Platform2026-03-09T09:47:05+00:00

Indica Labs Surpasses 3,000 Deployments of HALO Digital Pathology Software Worldwide Since 2013

2026-03-09T09:47:11+00:00

Indica Labs, the global leader in AI-powered digital pathology software and services, today announces surpassing the 3,000th installation of HALO software worldwide. HALO software provides transformative digital pathology solutions that span the entire bench to bedside continuum, from research and discovery to clinical research and primary diagnosis applications that in turn inform research pipelines. As HALO platforms [...]

Indica Labs Surpasses 3,000 Deployments of HALO Digital Pathology Software Worldwide Since 20132026-03-09T09:47:11+00:00

Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

2026-03-05T10:33:22+00:00

Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions Proscia® has cemented its position as the top-performing digital pathology software company. A new report from KLAS Research awarded Proscia the highest overall performance score (95.2)* in the US market, based entirely on customer feedback. The Digital [...]

Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings2026-03-05T10:33:22+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top